Joshua Hare, Chief Scientific Officer at Longeveron Inc. (LGVN), bought 1,000 shares at $8.23 ($8K) on 2021-02-12, disclosed to the SEC on 2021-02-17.
Open-market purchase of $8k LGVN by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LGVN | SELL | 2023-01-30 | $86K | — | Filing → |
| LGVN | SELL | 2022-12-05 | $75K | — | Filing → |
| LGVN | SELL | 2022-10-18 | $361K | — | Filing → |